glp-1 mrna increases IGF-1R protein but not expression in MIN6 cells GLP-1/GLP-1R: The Star Target for

Early and late-stage clinical trial coverage has reported major weight-loss results, and some discussions have focused on whether retatrutide may help support better body composition during weight loss

Ozempic Gastroparesis Lawsuit and Rule 702 Key Hearing For Expert Reports The Federal Court in the Eastern District of Pennsylvania held a key hearing ( Rule 702) to decide whether scientific evidence and further evidence from expert opinions linking Ozempic and other semaglutide medications to gastroparesis (stomach paralysis) could be admitted

Elkeeb R, Eid T, Yu J, Nguyen H, Atef E

Gallbladder diseases Gallbladder disease was added to semaglutide warning labels in March 2022

Keep in mind that they may cause side effects such as nausea, vomiting, or gastrointestinal discomfort